Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation.

Respiratory syncytial virus (RSV) pneumonia in marrow transplant recipients is associated with significant mortality. Ribavirin is a nucleoside analog with activity against RSV and in its aerosolized formulation is the only drug approved for treatment of RSV pneumonia in the United States. The clini...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Lewinsohn, D M, Bowden, R A, Mattson, D, Crawford, S W
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1996
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163574/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8913463/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.11.2555
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!